相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-151
Kyung Hwan Kim et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
Yongsheng Jia et al.
MOLECULAR THERAPY (2021)
Tissue-resident memory T cells in breast cancer control and immunotherapy responses
Ann Byrne et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
Angela Ogden et al.
SCIENTIFIC REPORTS (2020)
In Vivo CD4(+) T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm
Mikel Ruterbusch et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy
Hiroshi Kagamu et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
Tao Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
Shiwani Agarwal et al.
MOLECULAR THERAPY (2020)
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer
Ylia Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity
Stephen T. Ferris et al.
NATURE (2020)
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
Nicolas Gonzalo Nunez et al.
NATURE COMMUNICATIONS (2020)
Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo
Loral Showalter et al.
Oncotarget (2020)
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai et al.
NATURE IMMUNOLOGY (2020)
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Qi Peng et al.
NATURE COMMUNICATIONS (2020)
Neoantigen-specific CD4+T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy
Peng Peng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki et al.
BLOOD ADVANCES (2020)
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses
Carlos A. Arbelaez et al.
NPJ VACCINES (2020)
A liposomal RNA vaccine inducing neoantigen-specific CD4+T cells augments the antitumor activity of local radiotherapy in mice
Nadja Salomon et al.
ONCOIMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Helper T cell differentiation
Jordy Saravia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction
Jolie G. Cullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancer
Satomi Watanabe et al.
CANCER MEDICINE (2019)
T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
Shane Crotty
IMMUNITY (2019)
Dendritic Cell-Mediated Th2 Immunity and Immune Disorders
Sunil Kumar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Endogenous CD4+ thorn T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
Joshua R. Veatch et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer
James Clarke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
Heather Scharpenseel et al.
SCIENTIFIC REPORTS (2019)
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
Rajkumar Noubade et al.
FRONTIERS IN IMMUNOLOGY (2019)
On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored
Peter Bretscher
FRONTIERS IN IMMUNOLOGY (2019)
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Song Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
Krithika N. Kodumudi et al.
FRONTIERS IN IMMUNOLOGY (2019)
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
Elena Tondini et al.
ONCOIMMUNOLOGY (2019)
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
Tiziana Triulzi et al.
ONCOIMMUNOLOGY (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Evelyn Menares et al.
NATURE COMMUNICATIONS (2019)
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Activation of the IL-4/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells
Cuiping Fu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The TNF Paradox in Cancer Progression and Immunotherapy (vol 10, 1818, 2019)
Anne Montfort et al.
FRONTIERS IN IMMUNOLOGY (2019)
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
Amaia Eleonora Maennling et al.
CANCERS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
Ryan Zander et al.
IMMUNITY (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
Tomasz Ahrends et al.
NATURE COMMUNICATIONS (2019)
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization
Hae Lim Lee et al.
SCIENTIFIC REPORTS (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
Expression-based immune signatures as predictors of neoadjuvant targeted-/chemo-therapy response: Experience from the I-SPY 2 TRIAL of ∼1000 patients across 10 therapies
C. Yau et al.
CANCER RESEARCH (2019)
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
Mojgan Ahmadzadeh et al.
SCIENCE IMMUNOLOGY (2019)
The Dark Side of IFN-: Its Role in Promoting Cancer Immunoevasion
Marija Mojic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
T Helper Cell Differentiation, Heterogeneity, and Plasticity
Jinfang Zhu
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
Yong Lu et al.
CANCER CELL (2018)
Anti-cancer therapy with TNFα and IFNγ:A comprehensive review
Jing Shen et al.
CELL PROLIFERATION (2018)
The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination
Joshua I. Gray et al.
IMMUNOLOGY (2018)
Dendritic Cell-Based Cancer Vaccines
Patricia M. Santos et al.
JOURNAL OF IMMUNOLOGY (2018)
IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
Hussein F. Aqbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma
Kendra C. Foley et al.
MELANOMA RESEARCH (2018)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma
Yasuo Takashima et al.
Oncotarget (2018)
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
Cinthia Rosemblit et al.
Oncotarget (2018)
Prospects of IL-2 in Cancer Immunotherapy
Hani Choudhry et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Steven F. Josephs et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Dendritic cell vaccines for high-grade gliomas
Matthew E. Eagles et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Determination of T Follicular Helper Cell Fate by Dendritic Cells
Jayendra Kumar Krishnaswamy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology
Lei Qin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Dormant tumour cells, their niches and the influence of immunity
Erica T. Goddard et al.
NATURE CELL BIOLOGY (2018)
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
Lorenzo Mortara et al.
FRONTIERS IN IMMUNOLOGY (2018)
Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act
Vandana Kalia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity
Dongrui Wang et al.
JCI INSIGHT (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer
Mark Jesus M. Magbanua et al.
NPJ BREAST CANCER (2018)
TH2 cell development and function
Jennifer A. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
HER3 signaling and targeted therapy in cancer
Rosalin Mishra et al.
ONCOLOGY REVIEWS (2018)
Multiple effects of CD40-CD40L axis in immunity against infection and cancer
Anjuman Ara et al.
IMMUNOTARGETS AND THERAPY (2018)
Loss of Anti-HER-3 CD4+T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes
Megan Fracol et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial
Lea Lowenfeld et al.
CLINICAL CANCER RESEARCH (2017)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+and CD8+human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
Latha B. Pathangey et al.
ONCOTARGET (2017)
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
Takumi Kumai et al.
CANCER IMMUNOLOGY RESEARCH (2017)
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Tomasz Ahrends et al.
IMMUNITY (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
G. Nappo et al.
ONCOGENESIS (2017)
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
Arata Takeuchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor Immunology meets. Immunology: Modified cancer cells as professional APC for priming naive tumor-specific CD4+T cells
Farah Bou Nasser Eddine et al.
ONCOIMMUNOLOGY (2017)
Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme
Brittany A. Goods et al.
PLOS ONE (2017)
The clinical development of vaccines for HER2+ breast cancer: Current landscape and future perspectives
R. L. B. Costa et al.
CANCER TREATMENT REVIEWS (2017)
Vaccines targeting helper T cells for cancer immunotherapy
Marit Meissen et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Preclinical and clinical development of neoantigen vaccines
L. Li et al.
ANNALS OF ONCOLOGY (2017)
Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes
Kunyu Li et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells
Victor A. Gall et al.
CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Clinical Development of the E75 Vaccine in Breast Cancer
Guy T. Clifton et al.
BREAST CARE (2016)
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases
Ileana S. Mauldin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
Tomasz Ahrends et al.
CANCER RESEARCH (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Neoantigens encoded in the cancer genome
Ton N. Schumacher et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
IL-2, IL-7, and IL-15: Multistage regulators of CD4+ T helper cell differentiation
Kaitlin A. Read et al.
EXPERIMENTAL HEMATOLOGY (2016)
Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer
C. J. Hao et al.
GENETICS AND MOLECULAR RESEARCH (2016)
CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity
Sammy Bedoui et al.
IMMUNOLOGICAL REVIEWS (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
An essential role for the IL-2 receptor in Treg cell function
Takatoshi Chinen et al.
NATURE IMMUNOLOGY (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Yinghua Zhao et al.
NATURE COMMUNICATIONS (2016)
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
Kyle C. Strickland et al.
ONCOTARGET (2016)
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
M. Mego et al.
JOURNAL OF CANCER (2016)
Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma
Hirokazu Matsushita et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy
Jintong Chen et al.
OncoImmunology (2016)
Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer Role for Immune Monitoring
Jashodeep Datta et al.
JAMA ONCOLOGY (2016)
B cell regulation of the anti-tumor response and role in carcinogenesis
Marc Schwartz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
The multifaceted role of CD4+ T cells in CD8+ T cell memory
Brian J. Laidlaw et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The paradoxical role of IL-10 in immunity and cancer
Mark H. Mannino et al.
CANCER LETTERS (2015)
Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer
Frederique Vegran et al.
CANCER RESEARCH (2015)
CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer
Qianfei Zhang et al.
CANCER RESEARCH (2015)
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
Katherine Venmar Bankaitis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production
Jinfang Zhu
CYTOKINE (2015)
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
John P. Ray et al.
IMMUNITY (2015)
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential
Koen van de Ven et al.
IMMUNOTHERAPY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Identification of cDC1-and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
Andreas Schlitzer et al.
NATURE IMMUNOLOGY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
Z-Z Yang et al.
BLOOD CANCER JOURNAL (2015)
Th17 Cell Plasticity and Functions in Cancer Immunity
Leslie Guery et al.
BIOMED RESEARCH INTERNATIONAL (2015)
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Alexander J. Davenport et al.
CANCER IMMUNOLOGY RESEARCH (2015)
CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu-Expressing Cancers
Jashodeep Datta et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Ivan Liadi et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Progressive loss of anti-HER2 CD4+ T-helper type 1 response in breast tumorigenesis and the potential for immune restoration
Jashodeep Datta et al.
ONCOIMMUNOLOGY (2015)
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
Neil L. Berinstein et al.
ONCOIMMUNOLOGY (2015)
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
Brooke E. Howitt et al.
JAMA ONCOLOGY (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Type 2 cytokines: mechanisms and therapeutic strategies
Thomas A. Wynn
NATURE REVIEWS IMMUNOLOGY (2015)
The structural network of Interleukin-10 and its implications in inflammation and cancer
Ece Saliha Acuner-Ozbabacan et al.
BMC GENOMICS (2014)
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
Thinle Chodon et al.
CLINICAL CANCER RESEARCH (2014)
The IL-2 cytokine family in cancer immunotherapy
Geok Choo Sim et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
Shane Crotty
IMMUNITY (2014)
Targeting of erbB3 receptor to overcome resistance in cancer treatment
Jian Ma et al.
MOLECULAR CANCER (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Th9 cells, new players in adaptive immunity
Edgar Schmitt et al.
TRENDS IN IMMUNOLOGY (2014)
IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
Martin Oft
CANCER IMMUNOLOGY RESEARCH (2014)
Th17 cellsin cancer: the ultimate identity crisis
Stefanie R. Bailey et al.
FRONTIERS IN IMMUNOLOGY (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Human memory T cells: generation, compartmentalization and homeostasis
Donna L. Farber et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
CD40L expression permits CD8+ T cells to execute immunologic helper functions
Marco Frentsch et al.
BLOOD (2013)
HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients
Soo Youn Bae et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers
Chi-Chen Hong et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CD27-CD70 Costimulation Controls T Cell Immunity during Acute and Persistent Cytomegalovirus Infection
Suzanne P. M. Welten et al.
JOURNAL OF VIROLOGY (2013)
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine
Olivier Adotevi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Expanding roles for CD4T cells and their subpopulations in tumor immunity and therapy
Mark J. Dobrzanski
FRONTIERS IN ONCOLOGY (2013)
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
Julia Terhune et al.
VACCINES (2013)
Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression
Monika C. Wolkers et al.
BLOOD (2012)
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
Xuguang Tai et al.
BLOOD (2012)
CD4(+)T Cells: Differentiation and Functions
Rishi Vishal Luckheeram et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
STAT6-dependent and -independent mechanisms in Th2 polarization
Elisabeth Maier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4+ T Helper 1 Cell Differentiation
Joanna R. Groom et al.
IMMUNITY (2012)
Th17 cells have stem cell-like features and promote long-term immunity
Shuang Wei et al.
ONCOIMMUNOLOGY (2012)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
Ashutosh Chaudhry et al.
IMMUNITY (2011)
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
Pawel Muranski et al.
IMMUNITY (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Th Cells Act Via Two Synergistic Pathways To Promote Antiviral CD8+ T Cell Responses
Melanie Wiesel et al.
JOURNAL OF IMMUNOLOGY (2010)
HER3 overexpression in breast cancer conveys a poor prognosis
Lisa Richards
Nature Reviews Clinical Oncology (2010)
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
S. M. Tovey et al.
BRITISH JOURNAL OF CANCER (2009)
Quantitative Multiplexed Analysis of ErbB Family Coexpression for Primary Breast Cancer Prognosis in a Large Retrospective Cohort
Jennifer M. Giltnane et al.
CANCER (2009)
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Violaine Francois et al.
CANCER RESEARCH (2009)
HER2 overexpression correlates with survival after curative resection of pancreatic cancer
Masahiro Komoto et al.
CANCER SCIENCE (2009)
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
Pujya Agarwal et al.
JOURNAL OF IMMUNOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccine
Jong Myun Park et al.
CANCER RESEARCH (2008)
Endogenous Interleukin-4 Promotes Tumor Development by increasing Tumor Cell Resistance to Apoptosis
Zhiguang Li et al.
CANCER RESEARCH (2008)
TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help
Jilian A. Sacks et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
IL-15 as a mediator of CD4(+) help for CD8(+) T cell longevity and avoidance of TRAIL-mediated apoptosis
SangKon Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2
Stefania Varchetta et al.
CANCER RESEARCH (2007)
CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses
Patricia Novy et al.
JOURNAL OF IMMUNOLOGY (2007)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Human CD4+ T cells lyse target cells via Granzyme/Perforin upon circumvention of MHU class II restriction by an antibody-like immunoreceptor
Andreas Hombach et al.
JOURNAL OF IMMUNOLOGY (2006)
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction
F Castellino et al.
NATURE (2006)
Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: A role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation
MC Lebre et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas
JM Park et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cell-mediated T cell polarization
EC de Jong et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IL-12 enhances the generation of tumour antigen-specific Th1CD4 T cells during ex vivo expansion
KL Knutson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
SW Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation
RA Seder et al.
NATURE IMMUNOLOGY (2003)
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients:: Correlation with antibody responses
S Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development
MB Faries et al.
BLOOD (2001)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans
M Yasukawa et al.
BLOOD (2000)
分享论文
